Advancing our knowledge of viral membrane fusion and of IDP-membrane interactions by ESR
Advancing our knowledge of viral membrane fusion and of IDP-membrane interactions by ESR
批准号:
10552109
负责人:
Jack H Freed
金额:
$41.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-02-01 至 2028-01-31
关键词:
2019-nCoVBindingBiological ProcessC-terminalCOVID-19 pandemicCalorimetryCell WallCellsCircular DichroismDevelopmentDiseaseEbola virusElectron Spin Resonance SpectroscopyEmerging Communicable DiseasesExocytosisGoalsHIVHumanInfluenzaInfluenza HemagglutininKnowledgeLearningMembraneMembrane FusionMembrane ProteinsMethodologyMethodsMiddle East Respiratory SyndromeMiddle East Respiratory Syndrome CoronavirusModelingNatureNerve DegenerationOrganismPeptidesPropertyProteinsRoleSARS coronavirusSevere Acute Respiratory SyndromeStructureTechniquesTertiary Protein StructureTestingTitrationsTransmembrane DomainViralVirusVirus Diseasesbiophysical techniquescombatfightingflunervous system disordernew therapeutic targetpathogenic virus
中文摘要
点击翻译按钮获取中文摘要
英文摘要
For many years Freed has pioneered the development of electron-spin resonance (ESR) methods for the study
of proteins and their dynamical effects on membranes. The goal of this proposal is to use those ESR techniques
to advance our knowledge of 1) viral membrane fusion and 2) Intrinsic Disordered Protein (IDP)-membrane
interactions in conjunction with other biophysical methods.
The ongoing COVID19 pandemic has unveiled how limited are our knowledge and methods to combat
emerging infectious diseases caused by viral pathogens. A key step in SARS-CoV-2 (“SARS-2”) viral infection is
membrane fusion initiated by its fusion peptide (FP) domain in its Spike protein. In fact, membrane fusion is
key for all enveloped viruses such as SARS-CoV-1 (“SARS-1”), MERS-CoV, EBOV, influenza and HIV. However,
the mechanism of viral membrane fusion is still unclear. We have extensively demonstrated that FP-induced
membrane ordering is a prerequisite for viral membrane fusion in all these viruses. We have shown that
membrane ordering for some viruses including SARS-1, MERS and EBOV is strongly Ca2+-dependent. Most
recently we have shown that SARS-2 FP interacts with membranes more strongly than SARS-1, and it depends
very specifically on Ca2+. However, the exact role of Ca2+, as well as the mechanism of membrane ordering are
still unclear. The FP only initiates membrane fusion. We have proposed that the transmembrane domain (TMD)
of influenza hemagglutinin is important for finalizing membrane fusion. However, this remains to be tested to
see if it is applicable to SARS-2. Thus, we plan to continue studies of the mechanism of membrane fusion of
SARS-2 as well as other Ca2+-dependent viruses.
IDPs lack a stable tertiary structure in solution. After membrane binding, they can either undergo a disorder-
to-order transition or still remain in the absence of a stable structure. The viral FPs are such examples. This IDP-
membrane interaction localizes IDPs to their target membranes, facilitating interactions with other membrane
proteins, and helping to remodel membrane properties. Understanding the structure/function relationships
underlying IDP-membrane interactions is a significant challenge because of their highly variable and dynamic
nature. We have been using complexin, a key exocytosis regulator related to neurodegeneration, as a model to
delineate the IDP-membrane binding mode. We have found that complexins from different organisms have very
different modes, which is likely to reflect their different biological functions. We plan to continue to study the
membrane-binding C-terminal domain of complexins of several species to determine the mechanisms that
govern complexin-membrane binding modes. These findings will be useful for human therapies.
ESR is a powerful methodology to study the dynamic and structural properties of SARS FPs and other IDPs, as
we have shown. We will employ our well-developed ESR methods to achieve these goals. This will be
supplemented by other biophysical methods, including Isothermal Titration Calorimetry and Circular Dichroism.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Advancing our knowledge of viral membrane fusion and of IDP-membrane interactions by ESR
-
批准号:10798605
-
项目类别:
-
资助金额:$5.39万
-
财政年份:2023
-
负责人:Jack H Freed
-
依托单位:
X/Q Band Pulsed ENDOR Spectrometer
-
批准号:9074986
-
项目类别:
-
资助金额:$139.81万
-
财政年份:2016
-
负责人:Jack H Freed
-
依托单位:
National Biomedical Center for Advanced ESR Technology (ACERT)
-
批准号:9208899
-
项目类别:
-
资助金额:$152.62万
-
财政年份:2012
-
负责人:Jack H Freed
-
依托单位:
National Biomedical Center for Advanced ESR Technology (ACERT)
-
批准号:9897567
-
项目类别:
-
资助金额:$101.47万
-
财政年份:2012
-
负责人:Jack H Freed
-
依托单位:
TR&D 3 for ACERT, 2017-2021 funding period
-
批准号:10206165
-
项目类别:
-
资助金额:$18.59万
-
财政年份:2012
-
负责人:Jack H Freed
-
依托单位:
Dissemination for ACERT, 2017-2021 funding period
-
批准号:10206162
-
项目类别:
-
资助金额:$5.76万
-
财政年份:2012
-
负责人:Jack H Freed
-
依托单位:
National Biomedical Center for Advanced ESR Technology (ACERT)
-
批准号:9931889
-
项目类别:
-
资助金额:$17.88万
-
财政年份:2012
-
负责人:Jack H Freed
-
依托单位:
National Center for Advanced ESR Techology (ACERT)
-
批准号:10206160
-
项目类别:
-
资助金额:$1.27万
-
财政年份:2012
-
负责人:Jack H Freed
-
依托单位:
Collaboration/Service for ACERT, 2017-2021 funding period
-
批准号:10206168
-
项目类别:
-
资助金额:$10.51万
-
财政年份:2012
-
负责人:Jack H Freed
-
依托单位:
DBPs for ACERT, 2017-2021 funding period
-
批准号:10206167
-
项目类别:
-
资助金额:$10.61万
-
财政年份:2012
-
负责人:Jack H Freed
-
依托单位:
Training for ACERT, 2017-2021 funding period
-
批准号:10206161
-
项目类别:
-
资助金额:$5.26万
-
财政年份:2012
-
负责人:Jack H Freed
-
依托单位:
Supplement to NATIONAL CENTER FOR ADVANCED ESR TECHNOLOGY
-
批准号:8417782
-
项目类别:
-
资助金额:$41.46万
-
财政年份:2012
-
负责人:Jack H Freed
-
依托单位:
TR&D 1 for ACERT, 2017-2021 funding period
-
批准号:10206163
-
项目类别:
-
资助金额:$19.46万
-
财政年份:2012
-
负责人:Jack H Freed
-
依托单位:
TR&D 2 for ACERT, 2017-2021 funding period
-
批准号:10206164
-
项目类别:
-
资助金额:$16.5万
-
财政年份:2012
-
负责人:Jack H Freed
-
依托单位:
TR&D 4 for ACERT, 2017-2021 funding period
-
批准号:10206166
-
项目类别:
-
资助金额:$12.79万
-
财政年份:2012
-
负责人:Jack H Freed
-
依托单位:
National Biomedical Center for Advanced ESR Technology (ACERT)
-
批准号:10206159
-
项目类别:
-
资助金额:$100.75万
-
财政年份:2012
-
负责人:Jack H Freed
-
依托单位:
SEMI-ANALYTIC APPROACHES TO SPIN RELAXATION IN PROTEINS
-
批准号:8364065
-
项目类别:
-
资助金额:$0.37万
-
财政年份:2011
-
负责人:Jack H Freed
-
依托单位:
JOINT ANALYSIS OF ESR LINESHAPES AND PROTON NMR DISPERSION PROFILES
-
批准号:8364061
-
项目类别:
-
资助金额:$0.16万
-
财政年份:2011
-
负责人:Jack H Freed
-
依托单位:
WORKSHOP ON ESR MICROSCOPY AND ITS APPLICATIONS IN BIOMEDICAL ESR IMAGING
-
批准号:8364118
-
项目类别:
-
资助金额:$0.16万
-
财政年份:2011
-
负责人:Jack H Freed
-
依托单位:
PULSE SEQUENCES FOR PULSED AND FT-ESR: DISTANCE MEASUREMENTS
-
批准号:8363955
-
项目类别:
-
资助金额:$1.29万
-
财政年份:2011
-
负责人:Jack H Freed
-
依托单位:
国内基金
海外基金
登录
查看更多内容
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:32170319
-
项目类别:面上项目
-
资助金额:58.00万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:--
-
项目类别:--
-
资助金额:58万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
-
批准号:31672538
-
项目类别:面上项目
-
资助金额:62.0万元
-
批准年份:2016
-
负责人:孙跃峰
-
依托单位:
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
-
批准号:31372080
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:杨迎伍
-
依托单位:
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
-
批准号:81172529
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:杨其峰
-
依托单位:
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
-
批准号:81070952
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2010
-
负责人:刘师莲
-
依托单位:
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
-
批准号:30672361
-
项目类别:面上项目
-
资助金额:24.0万元
-
批准年份:2006
-
负责人:徐宁志
-
依托单位: